Supovec E, Hanzel J, Novak G, Manevski D, et al. First-line anti-TNF agents, ustekinumab and vedolizumab perform similarly in Crohn' disease, but not in ulcerative colitis. Eur J Gastroenterol Hepatol 2025 Feb 6. doi: 10.1097/MEG.0000000000002940.
PMID: 39970039